Zaid MA[auth] - Search Results

Year	Number of Results
1996	1
2001	2
2002	1
2003	3
2004	2
2005	2
2006	1
2007	2
2008	1
2009	2
2015	1
2017	3
2018	3
2019	1
2020	5
2021	3
2022	2
2023	8
2024	0

1

Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.

Kitko CL, Arora M, DeFilipp Z, Zaid MA, Di Stasi A, Radojcic V, Betts CB, Coussens LM, Meyers ML, Qamoos H, Ordentlich P, Kumar V, Quaranto C, Schmitt A, Gu Y, Blazar BR, Wang TP, Salhotra A, Pusic I, Jagasia M, Lee SJ. Kitko CL, et al. Among authors: zaid ma. J Clin Oncol. 2023 Apr 1;41(10):1864-1875. doi: 10.1200/JCO.22.00958. Epub 2022 Dec 2. J Clin Oncol. 2023. PMID: 36459673 Free PMC article. Clinical Trial.

2

Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia.

Agrawal V, Gbolahan OB, Stahl M, Zeidan AM, Zaid MA, Farag SS, Konig H. Agrawal V, et al. Among authors: zaid ma. Curr Cancer Drug Targets. 2020;20(7):473-489. doi: 10.2174/1568009620666200502011059. Curr Cancer Drug Targets. 2020. PMID: 32357813 Review.

3

Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma.

Johnson TS, Sudha P, Liu E, Blaney P, Morgan G, Chopra VS, Santos CD, Nixon M, Huang K, Suvannasankha A, Zaid MA, Abonour R, Walker BA. Johnson TS, et al. Among authors: zaid ma. Res Sq [Preprint]. 2023 Aug 16:rs.3.rs-3221549. doi: 10.21203/rs.3.rs-3221549/v1. Res Sq. 2023. PMID: 37645789 Free PMC article. Preprint.

4

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.

Ashkar R, Feldman DR, Adra N, Zaid MA, Funt SA, Althouse SK, Perkins SM, Snow CI, Lazzara KM, Sego LM, Quinn DI, Hanna NH, Einhorn LH, Albany C. Ashkar R, et al. Among authors: zaid ma. Invest New Drugs. 2021 Dec;39(6):1656-1663. doi: 10.1007/s10637-021-01134-1. Epub 2021 May 24. Invest New Drugs. 2021. PMID: 34031784 Free PMC article. Clinical Trial.

5

Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma.

Dong C, Cesarano A, Bombaci G, Reiter JL, Yu CY, Wang Y, Jiang Z, Zaid MA, Huang K, Lu X, Walker BA, Perna F, Liu Y. Dong C, et al. Among authors: zaid ma. Oncogene. 2021 Oct;40(42):6130-6138. doi: 10.1038/s41388-021-02005-y. Epub 2021 Sep 9. Oncogene. 2021. PMID: 34504297 Free PMC article.

6

Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to disease.

Johnson TS, Yu CY, Huang Z, Xu S, Wang T, Dong C, Shao W, Zaid MA, Huang X, Wang Y, Bartlett C, Zhang Y, Walker BA, Liu Y, Huang K, Zhang J. Johnson TS, et al. Among authors: zaid ma. Genome Med. 2022 Feb 1;14(1):11. doi: 10.1186/s13073-022-01012-2. Genome Med. 2022. PMID: 35105355 Free PMC article.

7

Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).

Taza F, Abonour R, Zaid MA, Althouse SK, Anouti B, Akel R, Hanna NH, Adra N, Einhorn LH. Taza F, et al. Among authors: zaid ma. Clin Genitourin Cancer. 2023 Apr;21(2):213-220. doi: 10.1016/j.clgc.2023.01.004. Epub 2023 Jan 18. Clin Genitourin Cancer. 2023. PMID: 36737276

8

Successful management of life-threatening post-COVID-19 cryptosporidiosis in a renal transplant patient: a case report.

Shrateh ON, Jobran A, Zaid MA, Saleh M. Shrateh ON, et al. Among authors: zaid ma. Pan Afr Med J. 2023 May 4;45:10. doi: 10.11604/pamj.2023.45.10.39548. eCollection 2023. Pan Afr Med J. 2023. PMID: 37346914 Free PMC article.

9

Rare coexistence of primary renal cell carcinoma and primary adrenal adenoma in a cushingoid patient: A case report.

Shrateh ON, Jobran AWM, Zaid MA, Alshoukhi MW. Shrateh ON, et al. Among authors: zaid ma. Urol Case Rep. 2023 May 1;48:102411. doi: 10.1016/j.eucr.2023.102411. eCollection 2023 May. Urol Case Rep. 2023. PMID: 37187763 Free PMC article.

10

Mechanistic insights into the inhibition of human placental glutathione S-transferase P1-1 by abscisic and gibberellic acids: An integrated experimental and computational study.

Zaid MA, Dalmizrak O, Teralı K, Ozer N. Zaid MA, et al. J Mol Recognit. 2023 Sep;36(9):e3050. doi: 10.1002/jmr.3050. Epub 2023 Aug 9. J Mol Recognit. 2023. PMID: 37555623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

37 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year